Repository logo
 
Publication

Evaluation of the anticancer potential of the macrofungus Pisolithus arhizus mycelium and culture medium

dc.contributor.authorSantos, Germana
dc.contributor.authorPreto, Marco
dc.contributor.authorVasconcelos, Vítor
dc.contributor.authorMartins, Rosário
dc.contributor.authorOliveira, Rui S.
dc.contributor.authorMartins, Rosario
dc.date.accessioned2025-05-15T14:38:09Z
dc.date.available2025-05-15T14:38:09Z
dc.date.issued2024-05
dc.description.abstractMacrofungi produce remarkable biomedical products that can make a significant contribution to health. Pisolithus arhizus is a fungal species of the phylum Basidiomycota. It is mainly found in association with the roots of some trees species, establishing a mutualistic relationship with them, facilitating the absorption of nutrients from the soil in exchange for carbohydrates produced by the host plant. As recently reviewed by us, this macrofungus has aroused great interest due to its promising therapeutic properties and bioactive effects. Crude extracts were prepared from the mycelium and culture medium of P.arhizus using a mixture of dichloromethane:methanol (2:1. The extracts were then separated into nine fractions using vacuum liquid chromatography. The fractions were tested for cytotoxicity against the RKO colon adenocarcinoma cell line and 3T3 fibroblasts cell line. Cell viability was assessed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction assay. Preliminary results revealed a dose dependent cytotoxicity against RKO cell line with no significant cytotoxicity to 3T3 cell lines, in fractions B and C. Those fractions corresponded to extraction with 70% Hex:30% EtOAc and 60% Hex:40% EtOAc, respectively. The results indicate that P.arhizus mycelium is a source of compounds with anticancer activity. However, more in-depth studies are needed to analyze the chemical compounds from the various parts of P. arhizus and investigate their biological and toxicological activities. Exploring the bioactive potential of P. arhizus is key to developing a complete understanding of its therapeutic benefits.por
dc.identifier.citationSantos, G., Preto, M., Vasconcelos, V., Martins, R., & Oliveira, R. S. (2024). Evaluation of the anticancer potential of the macrofungus Pisolithus arhizus mycelium and culture medium. Livro de Resumos do 17o Encontro de Investigação Jovem da U.Porto / Book of Abstracts Young Researchers Meeting of U.Porto, 740–741. https://www.up.pt/ijup/wp-content/uploads/sites/892/2024/05/Livro-de-Resumos_final.pdf
dc.identifier.isbn978-989-746-378-5
dc.identifier.urihttp://hdl.handle.net/10400.22/30085
dc.language.isoeng
dc.peerreviewedn/a
dc.publisherUniversidade do Porto
dc.relationUIDB/04423/2020; UIDP/04423/2020
dc.relation.hasversionhttps://www.up.pt/ijup/wp-content/uploads/sites/892/2024/05/Livro-de-Resumos_final.pdf
dc.rights.uriN/A
dc.subjectPisolithus Arhizus
dc.subjectMacrofungi
dc.subjectAnticancer potential
dc.titleEvaluation of the anticancer potential of the macrofungus Pisolithus arhizus mycelium and culture mediumpor
dc.typeconference poster
dspace.entity.typePublication
oaire.citation.conferenceDate2024-05
oaire.citation.conferencePlacePorto
oaire.citation.endPage741
oaire.citation.startPage740
oaire.citation.titleLivro de Resumos do 17.º Encontro de Investigação Jovem da U.Porto / Book of Abstracts Young Researchers Meeting of U.Porto
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameMartins
person.givenNameRosario
person.identifier.ciencia-idA919-DB40-EF10
person.identifier.orcid0000-0002-9882-4651
person.identifier.scopus-author-id21834368700
relation.isAuthorOfPublication82a7c349-c88e-450f-adc7-3331d69149cf
relation.isAuthorOfPublication.latestForDiscovery82a7c349-c88e-450f-adc7-3331d69149cf

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
POSTER_Rosário Martins.pdf
Size:
528 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description: